MARÍA DOLORES
CABALLERO BARRIGÓN
Researcher in the period 1998-2022
Skåne University Hospital
Lund, SueciaPublications in collaboration with researchers from Skåne University Hospital (1)
2016
-
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: An international, randomised, open-label, phase 3 study
The Lancet, Vol. 387, Núm. 10020, pp. 770-778